Podcast: Former FDA Commissioner On “Smarter Regulation”
Executive Summary
Former US FDA Commissioner Mark McClellan suggests the key with agency regulations may be how they are interpreted, and providing predictability and clarity, rather than just the scope of what’s written.
You may also be interested in...
US FDA’s Bipartisan Support May Offer Shelter From Political Winds, Former Chief Says
In the wake of 21st Century Cures legislation, next commissioner will have strong support across party lines to undertake smarter regulation aimed at improving the efficiency of the drug development process, former FDA head McClellan says.
Value-Based Contracts: Relief From Regulatory Barriers In Sight?
Novartis CEO Jimenez suggests Trump Administration may help remove regulatory barriers to US outcome-based contracting between manufacturers and payers; Duke Margolis Center for Health Policy plans policy initiative to promote value-based purchasing for drugs, medical devices and gene therapy.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.